Groowe Groowe / Newsroom / ULTX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ULTX News

Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight

prnewswire.com
NVO ULTX SGMO PFE BMN SNY CHGC RHHBY ALNY BIIB BAY TSEM CSL HEMA LFB OCT SOBI ASC